X. Wu et al. / Bioorg. Med. Chem. Lett. 19 (2009) 2957–2959
2959
for the Doctoral Program of Higher Education (No.
200506097003), and the Science and Technology Program Founda-
tion of Xi’an City (No. YF0707).
References and notes
1. Rossi, F. M.; Kao, J. P. Y. Bioconjugate Chem. 1997, 8, 495.
2. Lyttle, M. H.; Carter, T. G.; Cook, R. M. Org. Process Res. Dev. 2001, 5, 45.
3. Woodroofe, C. C.; Lim, M. H.; Bu, W.; Lipard, S. J. Tetrahedron 2005, 61, 3097.
4. Tian, M.; Wu, X. L.; Zhang, B.; Li, J. L.; Shi, Z. Bioorg. Med. Chem. Lett. 2008, 18,
1977.
5. Menchen, S. M.; Lee, L. G.; Connel, C. R.; Hershey, N. D.; Chakerian, V.; Woo, S. L.;
Fung, S.; U.S. Patent 6,649,598, 2003.
6. Khanna, P. L.; Ullman, E. F.; U.S. Patent 4,318,846, 1982.
Figure 3. Fluorescence images of U2OS cells in 96-well Costar black plate were
fixed with formaldehyde and stained with compound 1G. Images were taken under
fluorescence microscope with FITC channel.
7. The spectral of B: 1H NMR (CDCl3, 400 MHz) d 6.87 (s, 2H, 10 and 80-ArH), 7.81 (s,
1H, 5-ArH), 3.25 (s, 2H, –NH2), 1.44 (s, 18H, t-BuH), 1.24 (s, 12H, i-propyl H).
Anal. Calcd for C37H37Cl6NO9: C, 52.13; H, 4.38; N, 1.64. Found: C, 52.08; H, 4.39;
N, 1.66. MALDI-TOF MS, m/z: 852.52, (calcd: 852.41), IR (cmꢀ1): 2979, 2874,
1775, 1642, 1425, 1214, 1075, 682.Compound C: 1H NMR (CDCl3, 400 MHz) d
6.87 (s, 2H, 10 and 80-ArH), 8.20 (s, 1H, 5-ArH), 1.44 (s, 18H, t-BuH). Anal. Calcd
for C31H22Cl6O9: C, 49.56; H, 2.95. Found: C, 49.52; H, 2.94. MALDI-TOF MS, m/z:
751.30, (calcd: 751.22). IR (cmꢀ1): 2977, 1778, 1589, 1454, 1425, 1369, 1212,
1078.
8. The spectral of D: 1H NMR (CDCl3, 400 MHz) d 8.29 (s, 1H, 5-ArH), 6.88 (s, 2H, 10
and 80-ArH), 2.94 (t, 4H, –CH2CH2–), 1.45 (s, 18H, t-BuH). Anal. Calcd for
C35H25Cl6NO11: C, 49.56; H, 2.97; N, 1.65. Found: C, 49.61; H, 2.96; N, 1.67.
MALDI-TOF MS, m/z: 848.25, 751.86, (calcd: 848.29). IR (cmꢀ1): 3365, 2947,
1780, 1739, 1647, 1436, 1373, 1210, 1065, 647.
1
Compound 1E: H NMR (CDCl3, 400 MHz) d 6.89 (s, 2H, 10 and 80-ArH), 7.86 (s,
1H, 5-ArH), 3.52 (t, 2H, –CH2–), 1.67–1.72 (m, 2H, –CH2–), 1.47–1.51 (m, –CH2–),
2.39 (t, 2H, –CH2–), 1.44 (s, 18H, t-BuH). Anal. Calcd for C37H33Cl6NO10: C, 51.41;
H, 3.85; N, 1.62. Found: C, 51.39; H, 3.84; N, 1.59. MALDI-TOF MS, m/z: 861.11,
(calcd: 861.02). IR (cmꢀ1): 3378, 2975, 1778, 1657, 1551, 1454, 1424, 1372,
1211, 1079, 1026, 754.
1
Compound 2E: H NMR (CDCl3, 400 MHz) d 6.87 (s, 2H, 10 and 80-ArH), 7.83 (s,
Figure 4. Fluorescence Images of U2OS cells in 96-well Costar black plate were
fixed with formaldehyde and stained with compound 1G. Images were taken under
fluorescence microscope with TRITC channel.
1H, 5-ArH), 3.57 (t, 2H, –CH2–), 1.96–2.00 (m, 2H, –CH2–), 2.53 (t, 2H, –CH2–),
1.44 (s, 18H, t-BuH). Anal. Calcd for C35H29Cl6NO10: C, 50.26; H, 3.50; N, 1.67.
Found: C, 50.28; H, 3.51; N, 1.66. MALDI-TOF MS, m/z: 837.26, (calcd: 836.32). IR
(cmꢀ1): 3371, 2977, 1778, 1657, 1547, 1454, 1424, 1373, 1211, 1079, 1026, 754.
1
Compound 1F: H NMR (CDCl3, 400 MHz) d 6.87 (s, 2H, 10 and 80-ArH), 7.82 (s,
between the fluorophore and the reactive group. We find that the
spacer of 6-aminohexanoic acid or 4-aminobutanoic acid signifi-
cantly reduces the fluorescence quenching effect of chlorinated
fluorescein on proteins, even at relatively high degrees of labeling.
In addition, these novel fluorescent proteins-labeling probes can be
conjugated to proteins in the physiological pH range at room tem-
perature and with greater reproducibility. The pH sensitivity of
these chlorinated fluorescein dyes in the weakly acidic range (pH
4–6) also makes these dyes useful as pH indicator for acidic organ-
elles of live cells. In order to determine the effectiveness of the
probe dyes we labeled U2OS cells with 1G (Figs. 3 and 4). From
these photographs, we can find that it has strong fluorescence
and biocompatibility. So, compound 1G is useful substitute for
fluorescein for fluorescence imaging applications. The biological
application of compound 2G is being studied.
1H, 5-ArH), 3.41 (t, 2H, –CH2–), 1.85ꢁ1.86 (m, 2H, –CH2–), 1.63–1.70 (m, 2H, –
CH2–), 2.34 (t, 2H, –CH2–). Anal. Calcd for C27H17Cl6NO8: C, 46.58; H, 2.46; N,
2.01. Found: C, 46.61; H, 2.44; N, 2.03. MALDI-TOF MS, m/z: 696.44, (calcd:
696.14). IR (cm-1): 3395, 2958, 1782, 1658, 1548, 1430, 1216, 1090, 746.
1
Compound 2F: H NMR (CDCl3, 400 MHz) d 7.11 (s, 2H, 10 and 80-ArH), 7.95 (s,
1H, 5-ArH), 3.45 (t, 2H, –CH2–), 1.72ꢁ1.80 (m, 2H, –CH2–), 2.35 (t, 2H, –CH2–).
Anal. Calcd for C25H13Cl6NO8: C, 44.94; H, 1.96; N, 2.10. Found: C, 44.95; H, 1.95;
N, 2.09. MALDI-TOF MS, m/z: 669.00, (calcd: 668.09). IR (cmꢀ1): 3579, 3333,
1772, 1646, 1559, 1436, 1198, 1150, 1092, 749.
Compound 1G: From Figure
1
kem = 550 nm, kex = 535 nm, 1H NMR (CDCl3,
400 MHz) d 11.20 (s, 1H, –COOH), 8.66 (s, 1H, ArOH), 7.91 (s, 1H, 5-ArH), 7.28 (s,
2H, 10 and 80-ArH), 3.40 (t, 2H, –CH2–), 1.63–1.71 (m, 2H, –CH2–), 1.52–1.58 (m,
2H, –CH2–), 1.44–1.48 (m, 2H, –CH2–), 2.69 (t, 2H, –CH2–), 2.80 (t, 4H, –CH2CH2–
). Anal. Calcd for C31H20Cl6N2O10: C, 46.94; H, 2.54; N, 3.53. Found: C, 46.89; H,
2.55; N, 3.49. MALDI-TOF MS, m/z: 792.84, (calcd: 793.22). IR (cmꢀ1): 3365,
2947, 1780, 1739, 1647, 1600, 1436, 1210, 1065, 647.
Compound 2G: From Figure
2
kem = 550 nm, kex = 535 nm, 1H NMR (CDCl3,
400 MHz) d 11.22 (s, 1H, –COOH), 8.78 (s, 1H, ArOH), 8.00 (s, 1H, 5-ArH), 7.29 (s,
2H, 10 and 80 -ArH), 3.44 (t, 2H, –CH2–), 1.88–1.91 (m, 2H, –CH2–), 2.73 (t, 2H, –
CH2–), 2.82 (t, 4H, –CH2CH2–). Anal. Calcd for C29H16Cl6N2O10: C, 45.52; H, 2.11;
N, 3.66. Found: C, 45.53; H, 2.10; N, 3.67. MALDI-TOF MS, m/z: 766.61, (calcd:
765.16). IR (cmꢀ1): 3318, 2981, 1785, 1732, 1649, 1600, 1430, 1207, 1064, 649.
Acknowledgments
The project was supported by the National Natural Science
Foundation of China (No. 20872117), Specialized Research Fund